Interplay Bio
MI - YpsilantiBiotechnology
Focus: Interplay Bio is a Michigan-based biotechnology company specializing in the LigandPro Platform for targeted protein degradation, focused on oncology. The company operates a portfolio model with multiple subsidiary programs and a research studio.
Profile data last refreshed 11h ago · AI intelligence enriched 1w ago
Open Jobs
16-2 this month
Stable — net -2 jobs in 30d
0 added, 2 removed. Backfill posture.
Should You Work at Interplay Bio?
AI assessmentInterplay Bio is a high-risk, early-stage platform play best suited for scientists seeking cutting-edge protein degradation exposure and tolerance for pre-clinical uncertainty.
Why Work Here
- Join a platform-focused biotech with proprietary LigandPro technology in the high-growth targeted protein degradation space
- Portfolio company structure provides exposure to multiple early-stage oncology programs and internal incubation opportunities
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Interplay Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.